2014-02-17 04:08:01 - Physician Views: Biosimilar Remicade Poised for Approval in Europe - Are Rheumatologists and Gastroenterologists Ready? - a new market research report on companiesandmarkets.com
This week´s Physician Views poll asks rheumatologists and gastroenterologists based in France, Germany, Italy, Spain and the UK:
- How they rate their understanding of the potential differences between biosimilars and reference biologics?
- If available today, to what percentage of new patients they would prescribe a biosimilar Remicade product?
- How comfortable they would be in prescribing a biosimilar Remicade product for the treatment of indications for which it has not been clinically tested directly?
- To what extent they anticipate that payers will dictate their future usage of biosimilar Remicade and other biosimilar anti-TNF products?
- What information/materials/support supplied by a biosimilar manufacturer would have the most positive impact on their usage of biosimilar products?
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.